Could a Georgetown Lab Finding Lead to New Treatment in Pancreatic Cancer?
February 27th, 2024
Learn more about exciting pancreatic research being conducted by Drs. Louis Weiner, Allison Fitzgerald, and Benjamin Weinberg. …
The Ruesch Center is thrilled to participate in a number of GI Cancer awareness activities, learn more and join us.
John Marshall, MD, defined the focus for the scientific briefing portion of this year’s symposium: young people getting GI cancers at an alarming rate.
Learn about new Ruesch faculty led GI cancer research, the potential impact of new grants and patient community-building initiatives.
One of the most meaningful gifts you can give cancer patients and their families is hope.
Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.
Caring for the whole person: Learn how a multi-disciplinary approach drives patient-centered care at The Ruesch Center for the Cure of Gastrointestinal Cancers
Could a Georgetown Lab Finding Lead to New Treatment in Pancreatic Cancer?
February 27th, 2024
Learn more about exciting pancreatic research being conducted by Drs. Louis Weiner, Allison Fitzgerald, and Benjamin Weinberg. …
Report: Cancer Incidence Rising in Adults Younger Than 50
February 27th, 2024
Dr. John Marshall shares his observations about the rise in early-onset Colorectal Cancer.…
Dr He on the Evaluation of Camrelizumab Plus Rivoceranib in Unresectable HCC
February 27th, 2024
Aiwu Ruth He, MD, PhD, discusses the evaluation of camrelizumab plus rivoceranib in unresectable hepatocellular carcinoma.…
Sign Up to receive all Ruesch updates directly in your Inbox
We will deliver information on upcoming educational events, current clinical trials, and cutting-edge research and trends in the GI cancer field.